𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids

✍ Scribed by Verena Prokosch; Solon Thanos; Kristina Spaniol; Tobias Stupp

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
471 KB
Volume
249
Category
Article
ISSN
0065-6100

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Imiquimod 5% cream for the treatment of
Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion
✍ W. Sterry; T. Ruzicka; E. Herrera; A. Takwale; J. Bichel; K. Andres; L. Ding; M. πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 351 KB

## Background: Imiquimod 5% cream has been investigated for non-surgical treatment of superficial and nodular basal cell carcinoma (bcc) tumours. ## Objectives: Two studies were conducted to examine the effect of occlusion at low dosing frequencies on the safety and efficacy of topical imiquimod

High dose chemotherapy with autologous s
High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma : Long term results for 105 patients
✍ Takao Shinozuka; Tsuyoshi Miyamoto; Toshinari Muramatsu; Takeshi Hirasawa; Masar πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 2 views

## BACKGROUND. In this study, the authors reviewed long term results and prognostic factors of high dose chemotherapy (HDC) with autologous stem cell support administered to 105 patients with epithelial ovarian carcinoma. ## METHODS. Prior to HDC, platinum-based chemotherapy was given to optimi